Visual assessment of Ki67 at a glance is an easy method to exclude many luminal-type breast cancers from counting 1000 cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Visual assessment of Ki67 at a glance is an easy method to exclude many luminal-type breast cancers from counting 1000 cells
Authors
Keywords
Ki67, MIB-1, Breast cancer, Luminal subtype, Visual assessment
Journal
Breast Cancer
Volume 22, Issue 2, Pages 129-134
Publisher
Springer Nature
Online
2013-03-30
DOI
10.1007/s12282-013-0460-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer
- (2012) S Barton et al. BRITISH JOURNAL OF CANCER
- How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
- (2012) Zsuzsanna Varga et al. PLoS One
- Is the Ki-67 labelling index ready for clinical use?
- (2011) W. Jonat et al. ANNALS OF ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
- (2011) S Fasanella et al. Diagnostic Pathology
- High estrogen receptor expression and low Ki67 expression are associated with improved time to progression during first-line endocrine therapy with aromatase inhibitors in breast cancer
- (2011) Yumi Endo et al. International Journal of Clinical Oncology
- Clinical Notice for American Society of Clinical Oncology-College of American Pathologists Guideline Recommendations on ER/PgR and HER2 Testing in Breast Cancer
- (2011) M. Elizabeth Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
- (2011) Reiki Nishimura et al. World Journal of Surgical Oncology
- Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer
- (2010) A. DeCensi et al. ANNALS OF ONCOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative validation of the SP6 antibody to Ki67 in breast cancer
- (2010) L. Zabaglo et al. JOURNAL OF CLINICAL PATHOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis
- (2009) Reiki Nishimura et al. Breast Cancer
- Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
- (2008) Giuseppe Viale et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer
- (2008) Giuseppe Viale et al. JNCI-Journal of the National Cancer Institute
- Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics
- (2008) M. J. Ellis et al. JNCI-Journal of the National Cancer Institute
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started